How people with diabetes find and use health information in Reunion and mainland France
Official title: Exploration of Health Literacy in Diabetes in Reunion Island and Metropolitan France
Run by Centre Hospitalier Universitaire de la Réunion · NCT06437782 · Data updated 2026-11-12
This project will see how well people with type 1, type 2, or gestational diabetes in Reunion and France understand and use health information by having them complete a single health literacy questionnaire.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1350 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de la Réunion Academic / other |
| Locations | 2 sites (Saint-Denis and 1 other locations) |
| Status | Recruiting |
| Started | April 17, 2025 |
| Main results expected | April 2027 |
| Study ends | June 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06437782 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with type 1, type 2, or gestational diabetes receiving care at the CHU de La Réunion who can consent and do not have cognitive impairment or recent serious complications are ideal candidates.
✕Probably not a fit
Patients with cognitive disorders, recent serious diabetic complications, stroke with lasting deficits, or rare/secondary diabetes types are unlikely to be eligible or to benefit from this questionnaire-based profiling.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational effort aims to map health literacy profiles of people with type 1, type 2, or gestational diabetes in Reunion Island and France. Participants recruited at the CHU de La Réunion will complete the Health Literacy Questionnaire (HLQ) once to measure multiple domains of health literacy. Individuals with cognitive disorders, recent serious diabetic complications, stroke-related deficits, or certain secondary/rare diabetes types are excluded, and only patients able to follow study procedures will be enrolled. The resulting profiles are intended to inform improvements in information access, therapeutic education, and regional health service delivery for diabetic patients.
Why it matters
Potential benefit: If successful, the results could help tailor education and information so people with diabetes find care and manage their condition more effectively.
How similar studies have gone: The Health Literacy Questionnaire is a validated tool and similar HLQ-based profiling studies have been used elsewhere to guide education programs, though direct effects on clinical outcomes have been variable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient with type 1, 2 or gestational diabetes taken care in hospital Exclusion Criteria: * Patient unable to understand and respect study procedures * Patient with cognitive disorder * Patient with serious acute complication due to diabetes within 15 days before inclusion * Stroke history with neurologic consequences * Other specific types of diabetes : chronic calcific pancreatitis, iatrogenic, other secondary diabetes, rare monogenic or genetic diabetes due to insulin resistance
Where it's running
-
CHU de La Réunion
Saint-Denis, Reunion Recruiting -
CHU de La Réunion
Saint-Denis, Reunion Not yet recruiting
Study contacts
- Study coordinator: Anna FLAUS
- Email: anna.flaus-furmaniuk@chu-reunion.fr
- Phone: +262262905610
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes
This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Perioperative Meditation Music for Type 2 Diabetes Patients Undergoing Elective Surgery
We’re testing whether playing self-selected meditation music around surgery helps adults with type 2 diabetes stay calm, sleep better, and keep blood sugar steadier.
-
How metformin works in people with or without the SLC16A11 risk variant
This study tests whether the SLC16A11 genetic variant changes how adults with type 2 diabetes respond to metformin over 6 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.